MAAPC Dinner Annapolis December 1
The Lodge Annapolis
177 Jennifer Road
Annapolis, MD 21401
Monday, December 1, 2025 at 6:30pm ET - 9:00pm ET
Add this event to your calendar
Info
Topic
CRYSVITA® (burosumab-twza): Targeted Treatment for Adults With X-Linked Hypophosphatemia (XLH) – Focus: Patient Cases - Other Specialties
Attachments
Invitation Flyer
(290 KB)
Additional Information
CRYSVITA® (burosumab-twza) is a fibroblast growth factor 23 (FGF23) blocking antibody indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
Speaker:
Bonnie Smeryage, DNP, FNP-C
Nurse Practitioner
Joe DiMaggio Children's Hospital Fort Lauderdale, FL